
Guardant Health, Inc.
NASDAQ:GH
Overview | Financials
Company Name | Guardant Health, Inc. |
Symbol | GH |
Currency | USD |
Price | 40.64 |
Market Cap | 5,015,829,440 |
Dividend Yield | 0% |
52-week-range | 15.81 - 50.89 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Dr. Helmy Eltoukhy Ph.D. |
Website | https://guardanthealth.com |
An error occurred while fetching data.
About Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD